Demand for Thyroid Cancer Diagnostics in UK
Demand for Thyroid Cancer Diagnostics in UK Size and Share Forecast Outlook 2026 to 2036
Demand for thyroid cancer diagnostics in UK is projected to grow from USD 109.3 million in 2026 to USD 168.7 million by 2036, at a CAGR of 4.4%. Papillary Carcinoma will dominate with a 59.2% market share, while imaging will lead the diagnostic technique segment with a 43.5% share.
- FACT12717MR
- 16 Dec 2025
- Healthcare
- 170 Pages
- 6 Tables
- 21 Figures
Table of Content
- Executive Summary
- UK Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- UK Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- UK Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Cancer Type
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Cancer Type, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Cancer Type, 2026 to 2036
- Papillary Carcinoma
- Follicular Carcinoma
- Medullary Carcinoma
- Anaplastic Variants
- Y to o to Y Growth Trend Analysis By Cancer Type, 2021 to 2025
- Absolute $ Opportunity Analysis By Cancer Type, 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Diagnostic Technique
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Diagnostic Technique, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Diagnostic Technique, 2026 to 2036
- Imaging
- Biopsy
- Blood Tests
- Others
- Y to o to Y Growth Trend Analysis By Diagnostic Technique, 2021 to 2025
- Absolute $ Opportunity Analysis By Diagnostic Technique, 2026 to 2036
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- UK
- Market Attractiveness Analysis By Region
- UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- By Cancer Type
- By Diagnostic Technique
- Market Attractiveness Analysis
- By Country
- By Cancer Type
- By Diagnostic Technique
- Key Takeaways
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Cancer Type
- By Diagnostic Technique
- Competition Analysis
- Competition Deep Dive
- Abbott Laboratories
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- F. Hoffmann-La Roche Limited
- Thermo Fisher Scientific Incorporated
- Siemens Healthineers GmbH
- Bio-Rad Laboratories Incorporated
- GE HealthCare Technologies Incorporated
- Hologic Incorporated
- Koninklijke Philips N.V.
- Toshiba Corporation
- Agilent Technologies Incorporated
- Abbott Laboratories
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List Of Table
- Table 1: UK Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: UK Market Value (USD Million) Forecast by Cancer Type, 2021 to 2036
- Table 3: UK Market Value (USD Million) Forecast by Diagnostic Technique, 2021 to 2036
- Table 4: UK Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 5: UK Market Value (USD Million) Forecast by Cancer Type, 2021 to 2036
- Table 6: UK Market Value (USD Million) Forecast by Diagnostic Technique, 2021 to 2036
List Of Figures
- Figure 1: UK Market Pricing Analysis
- Figure 2: UK Market Value (USD Million) Forecast 2021 to 2036
- Figure 3: UK Market Value Share and BPS Analysis by Cancer Type, 2026 and 2036
- Figure 4: UK Market Y to o to Y Growth Comparison by Cancer Type, 2026 to 2036
- Figure 5: UK Market Attractiveness Analysis by Cancer Type
- Figure 6: UK Market Value Share and BPS Analysis by Diagnostic Technique, 2026 and 2036
- Figure 7: UK Market Y to o to Y Growth Comparison by Diagnostic Technique, 2026 to 2036
- Figure 8: UK Market Attractiveness Analysis by Diagnostic Technique
- Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2026 to 2036
- Figure 11: UK Market Attractiveness Analysis by Region
- Figure 12: UK Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 13: UK Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 14: UK Market Value Share and BPS Analysis by Cancer Type, 2026 and 2036
- Figure 15: UK Market Y to o to Y Growth Comparison by Cancer Type, 2026 to 2036
- Figure 16: UK Market Attractiveness Analysis by Cancer Type
- Figure 17: UK Market Value Share and BPS Analysis by Diagnostic Technique, 2026 and 2036
- Figure 18: UK Market Y to o to Y Growth Comparison by Diagnostic Technique, 2026 to 2036
- Figure 19: UK Market Attractiveness Analysis by Diagnostic Technique
- Figure 20: UK Market - Tier Structure Analysis
- Figure 21: UK Market - Company Share Analysis